```

[Federal Register Volume 85, Number 246 (Tuesday, December 22, 2020)]
[Notices]
[Pages 83587-83588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28163]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration

Meeting of the Advisory Committee on Infant Mortality

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Infant Mortality (ACIM) 
has scheduled a public meeting. Information about ACIM and the agenda 
for this meeting can be found on the ACIM website at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

DATES: January 25, 2021, 11:00 a.m.-6:00 p.m. Eastern Time (ET) and 
January 26, 2021, 11:00 a.m.-3:30 p.m. ET.

ADDRESSES: This meeting will be held via webinar. The webinar link and 
log-in information will be available at ACIM's website before the 
meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

FOR FURTHER INFORMATION CONTACT: David S. de la Cruz, Ph.D., MPH, 
Designated Federal Official, Maternal and Child Health Bureau (MCHB), 
HRSA, 5600 Fishers Lane, Room 18N25, Rockville, Maryland 20857; 301-
443-0543; or [email protected].

SUPPLEMENTARY INFORMATION: The ACIM is authorized by section 222 of the 
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee 
is governed by provisions of Public Law 92-463, as amended, (5 U.S.C. 
App. 2), which sets forth standards for the formation and use of 
Advisory Committees.
    The ACIM advises the Secretary of HHS on department activities and 
programs directed at reducing infant mortality and improving the health 
status of pregnant women and infants. The ACIM represents a public-
private partnership at the highest level to provide guidance and focus 
attention on the policies and resources required to address the 
reduction of infant mortality and the improvement of the health status 
of pregnant women and infants. With a focus on life course, the ACIM 
addresses disparities in maternal health to improve maternal health 
outcomes, including preventing and reducing maternal mortality and 
severe maternal morbidity. The ACIM provides advice on how best to 
coordinate myriad federal, state, local, and private programs and 
efforts that are designed to deal with the health and social problems 
impacting infant mortality and maternal health, including 
implementation of the Healthy Start

[[Page 83588]]

program and maternal and infant health objectives from the National 
Health Promotion and Disease Prevention Objectives (i.e., Healthy 
People 2030).
    The agenda for the January 25 and 26, 2021, meeting is being 
finalized and may include the following: Updates from HRSA, MCHB, and 
other federal agencies; continued discussion of the impact of COVID-19 
on infant and maternal health; immigrant maternal and child health 
issues; environmental contributions to infant mortality and maternal 
mortality; and updates on priority topic areas for ACIM to address 
(equity, data, access, and quality of care). Agenda items are subject 
to change as priorities dictate. Refer to the ACIM website for any 
updated information concerning the meeting.
    Members of the public will have the opportunity to provide written 
or oral comments. Requests to submit a written statement or make oral 
comments to the ACIM should be sent to David S. de la Cruz, using the 
email address above at least 3 business days prior to the meeting. 
Public participants may submit written statements in advance of the 
scheduled meeting by emailing [email protected]. Oral comments will be 
honored in the order they are requested and may be limited as time 
allows.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify David S. de la Cruz at 
the contact information listed above at least 10 business days prior to 
the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-28163 Filed 12-21-20; 8:45 am]
BILLING CODE 4165-15-P
```